Home » Stocks » BLFS

BioLife Solutions, Inc. (BLFS)

Stock Price: $31.51 USD -1.20 (-3.67%)
Updated Apr 20, 2021 4:00 PM EDT - Market closed
Market Cap 1.06B
Revenue (ttm) 48.09M
Net Income (ttm) 2.67M
Shares Out 27.31M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE 625.00
Dividend n/a
Dividend Yield n/a
Trading Day April 20
Last Price $31.51
Previous Close $32.71
Change ($) -1.20
Change (%) -3.67%
Day's Open 32.51
Day's Range 31.21 - 32.72
Day's Volume 146,999
52-Week Range 10.00 - 47.97

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

BOTHELL, Wash., April 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction produc...

5 days ago - PRNewsWire

HRC vs. BLFS: Which Stock Is the Better Value Option?

Other stocks mentioned: HRC
1 week ago - Zacks Investment Research

BOTHELL, Wash., April 6, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction produ...

2 weeks ago - PRNewsWire

HRC vs. BLFS: Which Stock Is the Better Value Option?

Other stocks mentioned: HRC
3 weeks ago - Zacks Investment Research

BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 0.00% and 9.67%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

4 weeks ago - Zacks Investment Research

Shares of BioLife Solutions (NASDAQ:BLFS) rose 9.7% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 0.00% year over year to ($0.01), which b...

4 weeks ago - Benzinga

COLUMBUS, Ohio, March 22, 2021 /PRNewswire/ -- Stirling Ultracold, an Ohio-based manufacturer and provider of the most energy efficient, sustainable ultra-low temperature (ULT) biorepositories has enter...

4 weeks ago - PRNewsWire

ATHENS, Ohio, March 22, 2021 /PRNewswire/ -- Stirling Ultracold, a privately-held innovative developer and manufacturer of ultra-low temperature (ULT) freezers, today announced it has signed a definitiv...

4 weeks ago - PRNewsWire

BOTHELL, Wash., March 22, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction prod...

4 weeks ago - PRNewsWire

BOTHELL, Wash., March 22, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction prod...

4 weeks ago - PRNewsWire

BOTHELL, Wash., March 10, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction produ...

1 month ago - PRNewsWire

HRC vs. BLFS: Which Stock Is the Better Value Option?

Other stocks mentioned: HRC
1 month ago - Zacks Investment Research

BioLife Solutions shares opened higher before moving sharply lower Thursday despite a higher analyst price target.

1 month ago - Investopedia

HRC vs. BLFS: Which Stock Is the Better Value Option?

Other stocks mentioned: HRC
2 months ago - Zacks Investment Research

Despite MedTech industry's bright prospects in 2021, investors should be wary of stocks like BLFS, STAA and TGTX, given their unfavorable Zacks Rank and weak fundamentals.

Other stocks mentioned: STAA, TGTX
3 months ago - Zacks Investment Research

BioLife Solutions, Inc.'s (BLFS) CEO Michael Rice on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

BOTHELL, Wash., Nov. 5, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products...

5 months ago - PRNewsWire

BOTHELL, Wash., Oct. 14, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools a...

6 months ago - PRNewsWire

Q2 2020 was a stellar quarter for BLFS in terms of revenue generation and new customer onboarding.

6 months ago - Seeking Alpha

It's a classic vertical integration move.

6 months ago - The Motley Fool

BOTHELL, Wash., Aug. 25, 2020 /PRNewswire/ -- BioLife Solutions, Inc.

7 months ago - PRNewsWire

Biolife Solutions, Inc. (BLFS) CEO Michael Rice on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

BOTHELL, Wash., Aug. 6, 2020 /PRNewswire/ -- BioLife Solutions, Inc.

8 months ago - PRNewsWire

BioLife (BLFS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

8 months ago - Zacks Investment Research

BOTHELL, Wash., July 30, 2020 /PRNewswire/ -- BioLife Solutions, Inc.

8 months ago - PRNewsWire

BOTHELL, Wash., July 7, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools fo...

9 months ago - PRNewsWire

BioLife Solutions, Inc. (BLFS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

9 months ago - Zacks Investment Research

BioLife (BLFS) saw a big move last session, as its shares jumped more than 12% on the day, amid huge volumes.

9 months ago - Zacks Investment Research

It doesn't look like the COVID-19 pandemic had much effect on sales of the company's bioproduction products for cell and gene therapies.

9 months ago - The Motley Fool

BOTHELL, Wash., July 2, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools fo...

9 months ago - PRNewsWire

BOTHELL, Wash., July 1, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools fo...

9 months ago - PRNewsWire

BOTHELL, Wash., May 18, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for...

11 months ago - PRNewsWire

The company experienced a 50% increase in its media revenues, although a considerable part of that is probably inflated by safety inventory building customers.

11 months ago - Seeking Alpha

BioLife Solutions, Inc. (BLFS) CEO Mike Rice on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

BOTHELL, Wash., May 14, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools fo...

11 months ago - PRNewsWire

BioLife Solutions (BLFS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

11 months ago - Zacks Investment Research

BioLife Will Suffer From Cancellations Of Trials

1 year ago - Seeking Alpha

BioLife Solutions' (BLFS) CEO Mike Rice on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

BioLife Solutions shares opened higher before moving sharply lower Thursday despite a higher analyst price target.

1 year ago - Investopedia

BioLife's Disappointing Quarter Masks A Much Better Future

1 year ago - Seeking Alpha

BioLife Solutions, Inc. (BLFS) CEO Mike Rice on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Biolife Solutions Digesting Big Gains; More To Follow

1 year ago - Seeking Alpha

The shares of BioLife have sold off last month, and those of competitor CryoPort much more, closing what we thought was an irrational valuation gap.

1 year ago - Seeking Alpha

Medical Products Industry Outlook: Prospects Seem Promising

Other stocks mentioned: APHA, SRDX
1 year ago - Zacks Investment Research

BioLife Solutions, Inc. (BLFS) CEO Mike Rice on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

CFO of Biolife Solutions Inc (30-Year Financial, Insider Trades) Greef Roderick De (insider trades) sold 30,000 shares of BLFS on 08/02/2019 at an average price of $18.96 a share.

1 year ago - GuruFocus

BioLife (BLFS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

We noticed a huge and recent valuation gap between BioLife and CryoPort, both operating in the regenerative medicine market supplying storage media and distribution solutions.

1 year ago - Seeking Alpha

Shares have risen by over 150% since my initial recommendation.

1 year ago - Seeking Alpha

Both companies operate in the same market and are of similar size and produce comparable growth rates, yet CryoPort sells at 2.5x the valuation of BioLife.

Other stocks mentioned: CYRX
1 year ago - Seeking Alpha

About BLFS

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line ... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Nov 22, 1989
CEO
Michael Rice
Employees
193
Stock Exchange
NASDAQ
Ticker Symbol
BLFS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 9 analysts, the average rating for BLFS stock is "Buy." The 12-month stock price forecast is 56.25, which is an increase of 78.51% from the latest price.

Price Target
$56.25
(78.51% upside)
Analyst Consensus: Buy